Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs
- 15 May 2004
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 12 (10) , 2517-2521
- https://doi.org/10.1016/j.bmc.2004.03.035
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.2003
- The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitorProceedings of the National Academy of Sciences, 2003
- Identifying inhibitors of the SARS coronavirus proteinaseBioorganic & Medicinal Chemistry Letters, 2003
- Old Drugs for a New BugPublished by American Medical Association (AMA) ,2003
- Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARSBiochemical and Biophysical Research Communications, 2003
- LGA: a method for finding 3D similarities in protein structuresNucleic Acids Research, 2003
- Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS DrugsScience, 2003
- Evaluation of protein docking predictions using Hex 3.1 in CAPRI rounds 1 and 2Proteins-Structure Function and Bioinformatics, 2003
- Improved prediction of HIV-1 protease-inhibitor binding energies by molecular dynamics simulations.Published by Institute of Electrical and Electronics Engineers (IEEE) ,2003
- Crystal Structures of HIV-1 Reverse Transcriptase in Complex with Carboxanilide Derivatives,Biochemistry, 1998